Combined regulation of neural cell production

Details Combined regulation of neural cell production Combined regulation of neural cell production

2006-01-30

2009-10-20

Gamett, Daniel C (Department: 1647)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of regulating cell metabolism or physiology

C435S365000, C435S368000, C424S198100, C514S012200, C530S399000

Reexamination Certificate

active

07604993

ABSTRACT:
This invention relates to a method of selectively producing neural cells, including neurons or glial cells, in vitro or in vivo. Also provided are methods of treating or ameliorating neurodegenerative disease or medical conditions by producing neural cells. Thus, a combination of factors is used to achieve two steps: increasing the number of neural stem cells and instructing the neural stem cells to selectively become neurons or glial cells.

REFERENCES:
patent: 4703008 (1987-10-01), Lin
patent: 4767628 (1988-08-01), Hutchinson
patent: 4801575 (1989-01-01), Pardridge
patent: 4902680 (1990-02-01), Aroonsakul
patent: 5023252 (1991-06-01), Hseih
patent: 5128242 (1992-07-01), Arimura et al.
patent: 5198542 (1993-03-01), Onda et al.
patent: 5208320 (1993-05-01), Kitada et al.
patent: 5231178 (1993-07-01), Holtz et al.
patent: 5268164 (1993-12-01), Kozarich et al.
patent: 5326860 (1994-07-01), Onda et al.
patent: 5328860 (1994-07-01), Lee et al.
patent: 5441868 (1995-08-01), Lin
patent: 5473054 (1995-12-01), Jameson et al.
patent: 5505206 (1996-04-01), Walloch
patent: 5506107 (1996-04-01), Cunningham et al.
patent: 5506206 (1996-04-01), Kozarich et al.
patent: 5521069 (1996-05-01), Onda et al.
patent: 5527527 (1996-06-01), Friden
patent: 5547935 (1996-08-01), Mullenbach et al.
patent: 5547993 (1996-08-01), Miki
patent: 5559143 (1996-09-01), McDonald et al.
patent: 5614184 (1997-03-01), Sytkowski et al.
patent: 5621080 (1997-04-01), Lin
patent: 5623050 (1997-04-01), Kitada et al.
patent: 5686416 (1997-11-01), Kozarich et al.
patent: 5723115 (1998-03-01), Serrero
patent: 5750376 (1998-05-01), Weiss et al.
patent: 5753506 (1998-05-01), Johe
patent: 5773569 (1998-06-01), Wrighton et al.
patent: 5795790 (1998-08-01), Schinstine et al.
patent: 5801147 (1998-09-01), Kitada et al.
patent: 5833988 (1998-11-01), Friden
patent: 5837460 (1998-11-01), Von Feldt et al.
patent: 5851832 (1998-12-01), Weiss et al.
patent: 5877169 (1999-03-01), Simpkins
patent: 5885574 (1999-03-01), Elliott
patent: 5955346 (1999-09-01), Wells et al.
patent: 5977307 (1999-11-01), Friden et al.
patent: 5980885 (1999-11-01), Weiss et al.
patent: 6015555 (2000-01-01), Friden
patent: 6017533 (2000-01-01), Moro et al.
patent: 6048971 (2000-04-01), Sytkowski et al.
patent: 6165783 (2000-12-01), Weiss et al.
patent: 6191106 (2001-02-01), Mullenbach et al.
patent: 6239105 (2001-05-01), Brewitt
patent: 6242563 (2001-06-01), Dong
patent: 6294346 (2001-09-01), Weiss et al.
patent: 6329508 (2001-12-01), Friden
patent: 6333031 (2001-12-01), Olsson et al.
patent: 6376218 (2002-04-01), Hsu et al.
patent: 6395546 (2002-05-01), Zobel et al.
patent: 6399316 (2002-06-01), Onda et al.
patent: 6413952 (2002-07-01), Luengo et al.
patent: 6429186 (2002-08-01), Fuh et al.
patent: 6551618 (2003-04-01), Baird et al.
patent: 6618698 (2003-09-01), Beausoleil et al.
patent: 6680295 (2004-01-01), Arimura
patent: 6797264 (2004-09-01), Eriksson
patent: 6812027 (2004-11-01), Goldman et al.
patent: 7048934 (2006-05-01), Thompson et al.
patent: 7132287 (2006-11-01), Rajan et al.
patent: 2002/0098178 (2002-07-01), Brand
patent: 2003/0032181 (2003-02-01), Weiss et al.
patent: 2003/0049838 (2003-03-01), Thompson et al.
patent: 2003/0054551 (2003-03-01), Shingo et al.
patent: 2003/0054998 (2003-03-01), Shingo et al.
patent: 2004/0038888 (2004-02-01), Mercer et al.
patent: 2004/0092448 (2004-05-01), Ohta et al.
patent: 2004/0209000 (2004-10-01), Curtiss et al.
patent: 2004/0209812 (2004-10-01), Renzi et al.
patent: 2005/0009847 (2005-01-01), Bertilsson et al.
patent: 2005/0245436 (2005-11-01), Weiss et al.
patent: 2006/0089309 (2006-04-01), Tucker
patent: 2006/0148084 (2006-07-01), Shingo et al.
patent: 2007/0098698 (2007-05-01), Gregg et al.
patent: 2007/0111932 (2007-05-01), Anderson
patent: 2007/0179092 (2007-08-01), Ohta et al.
patent: 2008/0039389 (2008-02-01), Weiss et al.
patent: 2008/0181873 (2008-07-01), Shingo et al.
patent: 2008/0286234 (2008-11-01), Eyink
patent: 2175992 (1995-05-01), None
patent: 2353553 (2000-06-01), None
patent: 2556266 (2005-08-01), None
patent: 0467279 (1992-01-01), None
patent: WO 90 05185 (1990-05-01), None
patent: WO 93 01275 (1993-01-01), None
patent: WO 9409119 (1994-04-01), None
patent: WO 94 10292 (1994-05-01), None
patent: WO 96 09318 (1996-03-01), None
patent: WO 96/40231 (1996-12-01), None
patent: WO 97/48729 (1997-12-01), None
patent: WO 99/15191 (1999-04-01), None
patent: WO 99/21966 (1999-05-01), None
patent: WO 99 51272 (1999-10-01), None
patent: WO 00/05260 (2000-02-01), None
patent: WO 00/13650 (2000-03-01), None
patent: WO 00 30675 (2000-06-01), None
patent: WO0128574 (2001-04-01), None
patent: WO 03 018782 (2003-03-01), None
patent: WO 03 024472 (2003-03-01), None
patent: WO 03 035475 (2003-05-01), None
patent: WO 03 040310 (2003-05-01), None
patent: WO 03 092716 (2003-11-01), None
patent: WO 2007106987 (2007-09-01), None
Brannvall et al., Molecular and Cellular Neuroscience, vol. 21, Issue 3, Nov. 2002, pp. 512-520.
Lim et al., Neuron, vol. 28, Issue 3, Dec. 2000, pp. 713-726.
Patil, A-A., “The Effect of Human Chorionic Gonadotropin (HCG) on Restoration of Physiological Contibuity of the Spinal Cord. A Preliminary Report” Int. Surg., Vol. 75, pp. 54-57, 1990.
Patil, A-A., “The Study of the Effect of Human Chorionic Gonadotrophic (HCG) Hormone on the Survival of Adrenal Medulla Transport in Brain. Preliminary Study” Acta Neurochirurgica, Vol. 87, pp. 76-78, 1987.
Patil, A-A. and Nagaraj, M.P., “The Effect of Human Chorionic Gonadotropin (HCG) on Functional Recovery of Spinal Cord Sectioned Rats*” Acta Neurochirurgica, Vol. 69, pp. 205-218, 1983.
Patil, A-A. and Nagaraj, M.P., Neurosurgery, Vol. 12, No. 5, pp. 593-594, 1983.
Arsenijevic et al., “Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2,” Journal of Neuroscience, pp. 7194-7202 (2001).
Lobie et al., “Growth hormone, insulin-like growth factor I and the CNS: localization, function and mechanism of action,” Growth Hormone & IGF Research, pp. S51-S56 (2000).
Bernichtein S., et al. (2001). S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist. Endocrinology. 142(9):3950-3963.
Cerami, A., et al. (2001). Effects of epoetin alfa on the central nervous system. Semin Oncol. 28(2 Suppl 8):66-70.
DiCicco-Bloom, E., et al. (1998). The PACAP ligand/receptor system regulates cerebral cortical neurogenesis. Ann N Y Acad Sci. 865:274-289.
Fernandez-Pol, J.A. (1985). Epidermal growth factor receptor of A431 cells. Characterization of a monoclonal anti-receptor antibody noncompetitive agonist of epidermal growth factor action. J Biol Chem. 260(8):5003-5011.
Gage, F.H. (2000). Mammalian neural stem cells. Science. 287(5457):1433-1438.
Johnson, D.L., and Jolliffe, L.K. (2000). Erythropoietin mimetic peptides and the future. Nephrol Dial Transplant. 15(9):1274-1277.
Kandel, E.R., et al. (1991). Principles of Neural Science, p. 981.
Kaushansky, K. (2001). Hematopoietic growth factor mimetics. Ann N Y Acad Sci. 938:131-138.
Kolb, B., et al. (1997). Nerve growth factor treatment prevents dendritic atrophy and promotes recovery of function after cortical injury. Neuroscience. 76(4):1139-1151.
Konishi, Y., et al. (1993). Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. 609(1-2):29-35.
Lee, M., et al. (2001). Pituitary adenylyl cyclase-activating polypeptide stimulates DNA synthesis but delays maturation of oligodendrocyte progenitors. J Neurosci. 21(11):3849-3859.
Livnah, O., et al. (1996). Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science. 273(5274):464-471.
Mode, A., et al. (1996). The human growth hormone (hGH) antagonist G120RhGH does not antagonize GH in the rat, but has paradoxical agonist activity, probably via the prolactin receptor. Endocrinology. 137(2):447-454.
Moro, O., Lerner, E.A. (1997). Maxadilan,

Affiliated with

Also associated with

Rating

Combined regulation of neural cell production does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined regulation of neural cell production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined regulation of neural cell production will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4076438